Study of blood test response in stent patients
Part of Heart & circulation clinical trials.
This study creates a registry to track long-term outcomes for people with chronic coronary syndrome (blockages that reduce blood flow to the heart) who are getting a planned stent. It will use a blood test to see how your body responds to anti-clotting medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You have chronic coronary syndrome (a condition where the heart's blood flow is blocked over time) and will have a planned, non-emergency stent procedure (PCI)
- You agree to sign a form giving your permission to be in the study before the procedure
- You are willing to have a blood test (VerifyNow test) to check how your blood reacts to anti-clotting drugs
- You do not have active bleeding, are not allergic to anti-clotting drugs, and if female, are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.